These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15213341)

  • 21. [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile].
    MMW Fortschr Med; 2005 Mar; 147(12):4. PubMed ID: 15832778
    [No Abstract]   [Full Text] [Related]  

  • 22. [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin].
    Griebenow R
    Internist (Berl); 2005 Mar; 46(3):350-2. PubMed ID: 15696286
    [No Abstract]   [Full Text] [Related]  

  • 23. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
    [No Abstract]   [Full Text] [Related]  

  • 24. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
    [No Abstract]   [Full Text] [Related]  

  • 25. Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank.
    Peissig P; Sirohi E; Berg RL; Brown-Switzer C; Ghebranious N; McCarty CA; Wilke RA
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):286-8. PubMed ID: 17371534
    [No Abstract]   [Full Text] [Related]  

  • 26. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
    Gangaidzo IT
    Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
    [No Abstract]   [Full Text] [Related]  

  • 27. [After TIA and stroke: a statin for secondary prevention?].
    MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
    [No Abstract]   [Full Text] [Related]  

  • 28. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
    Bern VH
    Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
    [No Abstract]   [Full Text] [Related]  

  • 29. Statins benefit people with high blood pressure.
    Harv Health Lett; 2003 Jun; 28(8):6. PubMed ID: 12835141
    [No Abstract]   [Full Text] [Related]  

  • 30. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 31. Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients.
    Goulas A; Kosmidou M; Hatzitolios AI; Molyva D; Fidani L; Giannopoulos S; Mirtsou V
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):559-62. PubMed ID: 18331394
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid arthritis treatment progressing.
    Health News; 2004 Aug; 10(8):9. PubMed ID: 15551458
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
    Charles-Schoeman C; Khanna D; Furst DE; McMahon M; Reddy ST; Fogelman AM; Paulus HE; Park GS; Gong T; Ansell BJ
    J Rheumatol; 2007 Jul; 34(7):1459-64. PubMed ID: 17552046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A; Sawicki PT
    MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract]   [Full Text] [Related]  

  • 36. The failure of torcetrapib: was it the molecule or the mechanism?
    Tall AR; Yvan-Charvet L; Wang N
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):257-60. PubMed ID: 17229967
    [No Abstract]   [Full Text] [Related]  

  • 37. New LDL goals: even lower?
    Johns Hopkins Med Lett Health After 50; 2004 Jul; 17(5):1-2, 7. PubMed ID: 15233099
    [No Abstract]   [Full Text] [Related]  

  • 38. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Media report of rare rhabdomyolysis cases seems to have triggered reluctance among some New Zealanders to use statins.
    Gladding PA; Kerr A; Edwards C
    N Z Med J; 2006 Sep; 119(1241):U2159. PubMed ID: 16964305
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effectiveness of tolmetin sodium in the treatment of infantile rheumatoid arthritis].
    Bini P; Giaretto G
    Minerva Pediatr; 1979 Mar; 31(6):483-4. PubMed ID: 470891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.